HUNTER SYNDROME
Clinical trials for HUNTER SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HUNTER SYNDROME trials appear
Sign up with your email to follow new studies for HUNTER SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks growth in kids with rare disease on enzyme therapy
Disease control CompletedThis study followed 21 children with Hunter Syndrome who started treatment with Elaprase before age 6. Researchers measured changes in height and weight over time to see how the drug affected growth. The study also monitored safety and compared results to untreated patients from …
Matched conditions: HUNTER SYNDROME
Phase: PHASE4 • Sponsor: Shire • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
Hunterase shows continued safety in hunter syndrome patients
Disease control CompletedThis study looked at the long-term safety and effectiveness of the drug Hunterase in people with Hunter syndrome. It included 30 patients who had already completed a previous study or had been using Hunterase for at least six months. Researchers monitored lab tests, physical exam…
Matched conditions: HUNTER SYNDROME
Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated May 14, 2026 12:02 UTC